24 completed, 6 unknown, 3 recruiting, 3 withdrawn. 12 Phase 3, 10 Phase 2, 9 Phase 4, 7 Phase 1, 6 Not applicable.
Follow Bromocriptine: new trials by email Literature Review of Bromocriptine trials Research Report on Bromocriptine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bromocriptine for Patients With Schizophrenia and Prediabetes Bromocriptine - Schizophrenia, PreDiabetes | Phase 4 | Not yet recruiting | VA Pittsburgh Healthcare System | 15 | 2026-01-01 | 2025-09-22 |
| A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets Cabergoline tablets, Bromocriptine mesylate tablets - Hyperprolactinemia | Phase 3 | Recruiting | Changchun GeneScience Pharmaceutical Co., Ltd. | 382 | 2025-09-12 | 2025-10-02 |
| Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age Bromocriptine mesylate plus standard GDMT - Dilated Cardiomyopathy | Phase 3 | Recruiting | Jimma University | 112 | 2024-10-21 | 2024-11-19 |
| Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy, Bromocriptin 2.5mg, 2-3 times a day - Pituitary Tumor | Not applicable | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 600 | 2024-10-01 | 2024-08-15 |
| Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy Bromocriptine, Placebo, Guideline Directed Medical Therapy for Heart Failure (GDMT) - Peripartum Cardiomyopathy, Postpartum | Phase 4 | Recruiting | Dennis M. McNamara, MD, MS | 250 | 2022-07-27 | 2026-08-10 |
| Psychobiological Mechanisms Underlying Chronic Pain Bromocriptine Mesylate Capsules, Amisulpride 400 MG, Placebo - Fibromyalgia, Pain, Chronic | Not applicable | Completed | susanne becker | 48 | 2021-11-01 | 2023-09-07 |
| Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa amisulpride, bromocriptine, Placebo - Anorexia Nervosa | Early Phase 1 | Completed | University of California, San Diego | 31 | 2020-10-20 | 2025-04-11 |
| Dapagliflozin Effect in Cognitive Impairment in Stroke Trial Dapagliflozin 10mg Tab, Statins (Cardiovascular Agents), Platelet Antiaggregant - Stroke, Ischemic, Mild Cognitive Impairment | Phase 2 / Phase 3 | Unknown | Jaime Daniel Mondragon | 270 | 2020-08-01 | 2022-10-04 |
| Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease Bromocriptine Mesilate, Placebos - Familial Alzheimer Disease (FAD), PSEN1 Mutation | Phase 1 / Phase 2 | Completed | Kyoto University | 8 | 2020-06-05 | 2025-08-29 |
| Satisfaction of Patients With the Chosen Method of Inhibition of Lactation Bromocriptine, Cabergoline, Natural methods - Lactation Suppressed | Not applicable | Unknown | Żelazna Medical Centre, LLC | 90 | 2019-06-16 | 2019-07-31 |
| Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response Fludrocortisone 0.1 Milligrams (mg), Bromocriptine - Ovarian Hyperstimulation Syndrome | Phase 2 | Completed | Ganin Fertility Center | 107 | 2019-04-01 | 2020-04-17 |
| Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury Bromocriptine 5 MG, Acetaminophen 650 MG - Subarachnoid Hemorrhage, Subdural Hematoma | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 47 | 2018-11-30 | 2021-06-24 |
| Dopamine Action on Metabolism in Relation to Genotype Bromocriptine, Placebo - Obesity | Phase 2 | Completed | University Hospital Tuebingen | 120 | 2018-05-03 | 2025-11-24 |
| Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME Bromocriptine 2.5 MG, Metoprolol 25 MG, Tamsulosin 0.4 MG - Diabetic Macular Edema | Phase 1 / Phase 2 | Withdrawn | Andrew Moshfeghi, MD, MBA | 2018-03-01 | 2019-04-01 | |
| Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM Placebo, Bromocriptine-QR - Overweight and Obesity, Eating Behavior | Phase 3 | Completed | University of North Carolina, Chapel Hill | 55 | 2017-09-19 | 2022-09-07 |
| Bromocriptine in the Treatment of Peripartum Cardiomyopathy Bromocriptine, Guideline-driven medical therapy (GDMT) - Peripartum Cardiomyopathy | Phase 3 | Withdrawn | Montreal Heart Institute | 2017-01-01 | 2023-04-04 | |
| Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome bromocriptine, dexamethasone - Ovarian Hyperstimulation Syndrome | Phase 2 | Unknown | Sun Yat-sen University | 200 | 2016-08-01 | 2016-07-27 |
| Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects Cycloset, Placebo - Diabetic Autonomic Neuropathy | Phase 4 | Completed | Eastern Virginia Medical School | 84 | 2015-10-05 | 2021-12-10 |
| Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes Bromocriptine, Placebo - Type 1 Diabetes | Phase 2 | Completed | University of Colorado, Denver | 108 | 2015-09-01 | 2021-09-13 |
| Bromocriptine and Insulin Sensitivity Bromocriptine - Insulin Sensitivity | Not applicable | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 15 | 2014-10-01 | 2016-05-24 |
Showing 20 of 41. Sign in to see all of them.
Diabetes Mellitus, Type 2 (5) · Parkinson Disease (5) · Obesity (4) · Insulin Resistance (3) · Peripartum Cardiomyopathy (3) · Diabetes Mellitus (2) · Hyperprolactinemia (2) · Ischemic Stroke (2) · Ovarian Hyperstimulation Syndrome (2) · Schizophrenia (2) · Acute Pain (1) · Adenomyosis (1) · Alzheimer Disease (1) · Anorexia Nervosa (1) · Behavior, Addictive (1)
Boehringer Ingelheim (3) · VeroScience (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Mylan Pharmaceuticals Inc (2) · Andrew Moshfeghi, MD, MBA (1) · Changchun GeneScience Pharmaceutical Co., Ltd. (1) · Dennis M. McNamara, MD, MS (1) · Eastern Virginia Medical School (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Ganin Fertility Center (1) · Hannover Medical School (1) · IWK Health Centre (1) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1) · Jaime Daniel Mondragon (1) · Jimma University (1)
United States (14) · Canada (5) · Germany (4) · China (3) · Mexico (3) · Netherlands (2) · Poland (2) · Argentina (1) · Brazil (1) · Bulgaria (1) · Chile (1) · Colombia (1) · Croatia (1) · Czechia (1) · Egypt (1)
Gaetano Morelli, M.D. (2) · Ali Imran, MD, FRCPC (1) · Andrew A. Moshfeghi, MD, MBA (1) · Andrew Kayser, MD,PhD (1) · Anique Ducharme, MD FRCPC (1) · Bindu Chamarthi, MD MMSc (1) · Denise Hilfiker-Kleiner, Prof. Dr. (1) · Dennis McNamara (1) · Dorota Sys, PhD (1) · Elizabeth Stewart, MD (1) · Estner F Heidi, MD, cardiologist (1) · Frits Holleman, Dr. MD (1) · Frits Holleman, Dr. MD. (1)
PMID 10368877, PMID 11710893, PMID 12457625, PMID 17289576, PMID 18455424, PMID 19146917, PMID 19445426, PMID 20204386, PMID 20308616, PMID 20332352, PMID 22596155, PMID 23040716, PMID 23316290, PMID 23619365, PMID 24847587, PMID 26026286, PMID 26060823, PMID 26792875, PMID 27339497, PMID 27687032, PMID 28095900, PMID 28374645, PMID 28934837, PMID 28950419, PMID 29016744, PMID 29260409, PMID 29371333, PMID 29446769, PMID 29573529, PMID 30051292, PMID 31132311, PMID 31236801, PMID 31248555, PMID 31488387, PMID 31535829, PMID 31974027, PMID 32115470, PMID 32144994, PMID 32178931, PMID 32277062, PMID 32298005, PMID 32317958, PMID 32352644, PMID 32559474, PMID 32854852, PMID 33030307, PMID 33282811, PMID 33461482, PMID 33894597, PMID 34193504
R21MH120475 (1), UG3HL153847 (1), UL1TR001082 (1)